Literature DB >> 1937071

Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients.

A Leys1, Y Vanrenterghem, B Van Damme, B Snyers, Y Pirson, M Leys.   

Abstract

A total of 23 patients aged between 11 and 64 years who had biopsy-proven membranoproliferative glomerulonephritis type II (dense deposit disease) were studied using fluorescein angiography of the retina. With the exception of two adolescents, all patients exhibited small subretinal nodules that were similar to basal laminar drusen. Subjects with a long history of renal disease displayed more numerous and larger nodules as well as atrophic changes. Four subjects presented with subretinal neovascular membranes.

Entities:  

Mesh：

Year:  1991        PMID： 1937071     DOI： 10.1007/bf00166300

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


  13 in total

1.  Specific eye fundus lesions in type II membranoproliferative glomerulonephritis.

Authors:  A Leys; W Proesmans; R Van Damme-Lombaerts; B Van Damme
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

2.  Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II.

Authors:  A Leys; B Michielsen; M Leys; Y Vanrenterghem; L Missotten; B Van Damme
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report.

Authors:  J Duvall-Young; M K MacDonald; N M McKechnie
Journal:  Br J Ophthalmol       Date:  1989-04       Impact factor: 4.638

4.  Type 2 membranoproliferative glomerulonephritis with electron-dense basement membrane alteration in the spleen.

Authors:  J Ormos; A Mágori; S Sonkodi; K Streitmann
Journal:  Arch Pathol Lab Med       Date:  1979-05       Impact factor: 5.534

5.  Electron dense alteration of kidney basement membranes. A renal lesion specific of a systemic disease.

Authors:  P Galle; P Mahieu
Journal:  Am J Med       Date:  1975-06       Impact factor: 4.965

6.  Extraglomerular dense deposits in dense deposit disease.

Authors:  P Thorner; R Baumal
Journal:  Arch Pathol Lab Med       Date:  1982-11       Impact factor: 5.534

7.  Lectin binding in membranoproliferative glomerulonephritis. Evidence for N-acetylglucosamine in dense intramembranous deposits.

Authors:  T E Nevins
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

8.  A clinical procedure for the simultaneous recording of fast and slow EOG oscillations.

Authors:  A De Rouck; D Kayembe
Journal:  Int Ophthalmol       Date:  1981-05       Impact factor: 2.031

9.  Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings.

Authors:  J Duvall-Young; C D Short; M F Raines; R Gokal; W Lawler
Journal:  Br J Ophthalmol       Date:  1989-11       Impact factor: 4.638
View more
  11 in total

Review 1.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 2.  Progress in defining the molecular biology of age related macular degeneration.

Authors:  Andrew Lotery; Dorothy Trump
Journal:  Hum Genet       Date:  2007-07-21       Impact factor: 4.132

Review 3.  Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).

Authors:  Hema L Ramkumar; Jun Zhang; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2010-03-03       Impact factor: 21.198

4.  Insights into pathology of cuticular drusen from integrated confocal scanning laser ophthalmoscopy imaging and corresponding spectral domain optical coherence tomography.

Authors:  Giuseppe Querques; Benjamin Guigui; Nicolas Leveziel; Lea Querques; Gabriel Coscas; Gisele Soubrane; Eric H Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-05-10       Impact factor: 3.117

5.  Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury.

Authors:  Joshua M Thurman; Brandon Renner; Kannan Kunchithapautham; Viviana P Ferreira; Michael K Pangburn; Zsolt Ablonczy; Stephen Tomlinson; V Michael Holers; Bärbel Rohrer
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

6.  Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction.

Authors:  Peter J Coffey; Carlos Gias; Caroline J McDermott; Peter Lundh; Matthew C Pickering; Charanjit Sethi; Alan Bird; Fred W Fitzke; Annelie Maass; Li Li Chen; Graham E Holder; Philip J Luthert; Thomas E Salt; Stephen E Moss; John Greenwood
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-05       Impact factor: 11.205

7.  [Patient with type II membranoproliferative glomerulonephritis: intravitreal bevacizumab therapy for choroidal neovascularization].

Authors:  M Karampelas; N Kopsachilis; J H Chang; B Pal
Journal:  Ophthalmologe       Date:  2012-08       Impact factor: 1.059

8.  Glycoproteins of drusen and drusen-like lesions.

Authors:  Yvonne D'souza; Carolyn J P Jones; Richard Bonshek
Journal:  J Mol Histol       Date:  2007-09-11       Impact factor: 2.611

Review 9.  Multimodal imaging of retinal pigment epithelial detachments in patients with C3 glomerulopathy: case report and review of the literature.

Authors:  Valeria Kheir; Ali Dirani; Matthieu Halfon; Jean-Pierre Venetz; Georges Halabi; Yan Guex-Crosier
Journal:  BMC Ophthalmol       Date:  2017-11-22       Impact factor: 2.209

10.  Retinal findings in membranoproliferative glomerulonephritis.

Authors:  Ahmad M Mansour; Luiz H Lima; J Fernando Arevalo; Miguel Hage Amaro; Virginia Lozano; Alaa Bou Ghannam; Errol W Chan
Journal:  Am J Ophthalmol Case Rep       Date:  2017-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.